The study looked at volumes of chemotherapy drugs for lung cancer patients after Congress cut Medicare reimbursements for them in 2003 as a cost-saving measure. The action was an attempt to close the gap between the Medicare reimbursement and the discounted rates physicians paid for the drugs.
Researchers had predicted Congress’ action would prompt physicians to avoid necessary use of the drug, but instead the study found volume of chemotherapy prescriptions rose significantly, particularly for the higher-cost drugs reimbursed at higher rates.
“The ultimate message is that payment reforms have real consequences and should be undertaken with caution,” the researchers said.
Read the Health Affairs report on reimbursements.
Read more stories on reimbursements.
Health Law’s Controversial Payment Board Holds Promise But May Backfire
9 Reimbursement and Business Concepts for Orthopedics in ASCs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
